Premier Alternatives

Avenzo Therapeutics

San Diego, CA · Founded 2022 · Privately Held (backing)

Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. Avenzo Therapeutics is based in San Diego, CA and was founded in 2022. It was valued at $590 million at its early-stage round in Aug 2025, the last priced event on record. It has raised $446 million across 2 recorded rounds; the latest was a $47.2 million early-stage round in Aug 2025.

PMV mark · valuation
$590.0M
Oct 2026
Priced at
its early-stage round
Aug 2025
Total raised
$445.9M
Last round
Early Stage VC
Aug 2025

Avenzo Therapeutics key facts

as of Oct 2026
  • Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers.
  • Avenzo Therapeutics is valued at approximately $590.0M as of Oct 2026, set at its early-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $445.9M across 2 recorded rounds; the latest was Early Stage VC ($47.2M) in Aug 2025.
  • Notable investors include New Enterprise Associates, OrbiMed, Sands Capital, Foresite Capital, INCE Capital — 15 tracked in total.
  • Avenzo Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently Sep 2025 ($47.2M sold to 20 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$590.0M

Valued at $590.0M at its early-stage round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Avenzo Therapeutics with a free account
  • ·The complete investor list: 15 names
  • ·Watch Avenzo Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Avenzo Therapeutics funding rounds

2 rounds
Aug 2025Early Stage VC$47.2MSEC filing▮
Sep 2022Later Stage VC$385.9MSEC filing▮
Full funding history →

Avenzo Therapeutics valuation

Avenzo Therapeutics was valued at $590 million at its early-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Avenzo Therapeutics raised?

Avenzo Therapeutics has raised $446 million across 2 recorded rounds since 2022. The largest was a $47.2 million early-stage round in Aug 2025.

Avenzo Therapeutics has filed 4 Form Ds with the SEC since 2022, most recently in Sep 2025 ($47.2 million sold to 20 investors).

Avenzo Therapeutics investors

15 investors are on record for Avenzo Therapeutics, including New Enterprise Associates, OrbiMed, Sands Capital and Foresite Capital. By type, the record holds 5 venture capital firms, 2 growth equity firms and 1 hedge fund. The early-stage round in Aug 2025 drew 20 investors.

About Avenzo Therapeutics

Operator of a clinical-stage oncology platform intended to develop novel treatments for underserved cancers. The company's platform offers a pipeline of oncology drug candidates, focusing on rare and genomically defined cancers, enabling researchers and patients to advance treatment through targeted therapies.

Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2022
Employees
45
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.